tm logo
RNA TO GO
Live/Registered
REGISTERED

on 26 Nov 2019

Last Applicant/ Owned by

FRIEDRICH-MIESCHER-STRASSE 15

TUBINGEN

DE

72076

Serial Number

88149613 filed on 10th Oct 2018

Registration Number

5918021 registered on 26th Nov 2019

in the Principal Register

Correspondent Address

JENNIFER FRASER

DYKEMA GOSSETT PLLC

1301 K ST., NW

SUITE 1100 WEST

WASHINGTON, DC 20005

Filing Basis

No Filing Basis

Disclaimer

"RNA"

RNA TO GO

Chemical preparations for medical use, namely, for therapeutic and prophylactic treatment of neurological, neuromuscular, neurodegenerative, infectious and cardiovascular diseases, of autoimmune diseases and tumours, of allergies, of metabolic diseases, of heritable genetic diseases, and for therapies replacing proteins or enzymes; pharmaceutical preparations, namely, immunostimulants, in particulRead More

Classification Information


Class [001]
Chemical Products


Chemical reagents and biomolecules, in particular biological macromolecules in the nature of nucleic acid for industrial or scientific purposes; Reagents for research purposes

Class [005]
Pharmaceutical Products


Chemical preparations for medical use, namely, for therapeutic and prophylactic treatment of neurological, neuromuscular, neurodegenerative, infectious and cardiovascular diseases, of autoimmune diseases and tumours, of allergies, of metabolic diseases, of heritable genetic diseases, and for therapies replacing proteins or enzymes; pharmaceutical preparations, namely, immunostimulants, in particular for human or veterinary medical purposes; pharmaceutical preparations, namely, vaccines, in particular for human or veterinary medical purposes; pharmaceutical preparations, namely, adjuvant immunostimulants; pharmaceuticals and medicaments containing biological macromolecules, in particular for human or veterinary purposes for the treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases, for the treatment of infectious diseases, autoimmune diseases and tumours, for treatment of metabolic diseases and for treatment of heritable genetic diseases and for protein or enzyme replacement therapy; gene therapy products, namely, nucleic acid macromolecules for in vivo expression for human or veterinary medical use; Dietetic substances adapted for medical use, in particular substances for food supplements namely, dietary food supplements

Class [042]
Computer & Software Services & Scientific Services


Scientific and technological services, namely, technical biology consulting and scientific research services, in particular for identifying and characterizing biological macromolecules; pre-clinical and clinical testing of macromolecules

Class [044]
Medical, Beauty & Agricultural Services


Medical and veterinary services, in particular for therapeutic and preventative treatment of tumour diseases, infectious diseases, autoimmune disorders and allergies, for treatment of inherited genetic diseases or for protein or enzyme replacement therapy, and for treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases, and for treatment of metabolic disorders

Mark Details


Serial Number

No 88149613

Mark Type

No Service Mark

Attorney Docket Number

No 067249-0029

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
25th May 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
26th Nov 2019REGISTERED-PRINCIPAL REGISTER
10th Sep 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10th Sep 2019PUBLISHED FOR OPPOSITION
21st Aug 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07th Aug 2019APPROVED FOR PUB - PRINCIPAL REGISTER
07th Aug 2019EXAMINER'S AMENDMENT ENTERED
07th Aug 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07th Aug 2019EXAMINERS AMENDMENT E-MAILED
07th Aug 2019EXAMINERS AMENDMENT -WRITTEN